pmc-enju-pas Home  

PMC:2664230 / 145-2097 JSONTXT 17 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T469 0-9 NN denotes OBJECTIVE
T470 10-13 DT denotes The
T471 14-23 NN denotes objective
T472 24-26 IN denotes of
T473 27-31 DT denotes this
T2791 27-31 DT denotes this
T474 32-37 NN denotes study
T2792 32-37 NN denotes study
T475 38-41 VB denotes was
T2793 38-41 VB denotes was
T476 42-44 TO denotes to
T477 45-54 VB denotes determine
T478 55-58 DT denotes the
T479 59-65 NN denotes effect
T480 66-68 IN denotes of
T481 69-80 JJ denotes nonspecific
T482 81-98 NN denotes phosphodiesterase
T483 99-109 NN denotes inhibition
T484 110-112 IN denotes on
T485 113-126 NN denotes transcription
T486 127-133 NN denotes factor
T487 134-144 NN denotes activation
T488 145-148 CC denotes and
T489 149-154 NN denotes tumor
T490 155-163 NN denotes necrosis
T491 164-176 NN denotes factor-alpha
T492 177-178 -LRB- denotes (
T493 178-183 NN denotes TNF-α
T494 183-184 -RRB- denotes )
T495 185-195 NN denotes production
T496 196-198 IN denotes in
T497 199-217 NN denotes lipopolysaccharide
T498 218-219 -LRB- denotes (
T499 219-222 NN denotes LPS
T500 222-223 -RRB- denotes )
T501 223-234 JJ denotes -stimulated
T502 235-240 JJ denotes human
T503 241-252 JJ denotes mononuclear
T504 253-258 NN denotes cells
T505 261-273 NN denotes INTRODUCTION
T506 274-277 DT denotes The
T507 278-288 NN denotes production
T508 289-291 IN denotes of
T509 292-297 NN denotes TNF-α
T510 298-307 VB denotes following
T511 308-311 NN denotes LPS
T512 312-323 NN denotes stimulation
T513 324-326 VB denotes is
T514 327-330 CD denotes one
T515 331-333 IN denotes of
T516 334-337 DT denotes the
T517 338-341 JJ denotes key
T518 342-347 NN denotes steps
T519 348-350 IN denotes in
T520 351-360 JJ denotes bacterial
T521 361-367 NN denotes sepsis
T522 368-371 CC denotes and
T523 372-384 NN denotes inflammation
T524 386-389 DT denotes The
T525 390-399 NN denotes mechanism
T526 400-402 IN denotes by
T527 403-408 WDT denotes which
T528 409-426 NN denotes phosphodiesterase
T529 427-437 NN denotes inhibition
T530 438-444 VB denotes alters
T531 445-450 NN denotes TNF-α
T532 451-461 NN denotes production
T533 462-464 IN denotes in
T534 465-468 DT denotes the
T535 469-477 NN denotes presence
T536 478-480 IN denotes of
T537 481-484 NN denotes LPS
T538 485-492 VB denotes remains
T539 493-500 JJ denotes unclear
T540 503-510 NN denotes METHODS
T541 511-516 JJ denotes Human
T542 517-528 JJ denotes mononuclear
T543 529-534 NN denotes cells
T544 535-539 VB denotes were
T545 540-550 VB denotes stimulated
T546 551-555 IN denotes with
T547 556-559 NN denotes LPS
T548 560-561 -LRB- denotes (
T549 561-562 CD denotes 1
T550 563-568 NN denotes μg/mL
T551 568-569 -RRB- denotes )
T552 569-570 -COMMA- denotes ,
T553 571-573 IN denotes in
T554 574-577 DT denotes the
T555 578-586 NN denotes presence
T556 587-590 CC denotes and
T557 591-598 NN denotes absence
T558 599-601 IN denotes of
T559 602-616 NN denotes Pentoxifylline
T560 617-618 -LRB- denotes (
T561 618-621 NN denotes PTX
T562 621-622 -COLON- denotes ;
T563 623-625 CD denotes 20
T564 626-628 NN denotes mM
T565 628-629 -RRB- denotes )
T566 629-630 -COMMA- denotes ,
T567 631-632 DT denotes a
T568 633-644 JJ denotes nonspecific
T569 645-662 NN denotes phosphodiesterase
T570 663-672 NN denotes inhibitor
T571 674-681 JJ denotes Western
T572 682-690 NN denotes blotting
T573 691-693 IN denotes of
T574 694-708 VB denotes phosphorylated
T575 709-720 JJ denotes cytoplasmic
T576 721-726 NN denotes I-κBα
T577 726-727 -COMMA- denotes ,
T578 728-735 JJ denotes nuclear
T579 736-745 NN denotes factor-κB
T580 746-749 NN denotes p65
T581 750-751 -LRB- denotes (
T582 751-756 NN denotes NF-κB
T583 756-757 -RRB- denotes )
T584 757-758 -COMMA- denotes ,
T585 759-762 CC denotes and
T586 763-770 JJ denotes nuclear
T587 771-784 JJ denotes cAMP-response
T588 785-792 NN denotes element
T589 793-800 NN denotes binding
T590 801-808 NN denotes protein
T591 809-810 -LRB- denotes (
T592 810-814 NN denotes CREB
T593 814-815 -RRB- denotes )
T594 816-819 VB denotes was
T595 820-829 VB denotes performed
T596 831-834 NN denotes DNA
T597 835-842 NN denotes binding
T598 843-845 IN denotes of
T599 846-851 NN denotes NF-κB
T600 852-855 CC denotes and
T601 856-860 NN denotes CREB
T602 861-864 VB denotes was
T603 865-873 VB denotes verified
T604 874-876 IN denotes by
T605 877-892 JJ denotes electrophoretic
T606 893-901 NN denotes mobility
T607 902-907 NN denotes shift
T608 908-913 NN denotes assay
T609 915-920 NN denotes TNF-α
T610 921-927 NN denotes levels
T611 928-932 VB denotes were
T612 933-943 VB denotes determined
T613 944-946 IN denotes in
T614 947-950 DT denotes the
T615 951-962 NN denotes supernatant
T616 963-965 IN denotes of
T617 966-976 VB denotes stimulated
T618 977-982 NN denotes cells
T619 983-985 IN denotes in
T620 986-989 DT denotes the
T621 990-998 NN denotes presence
T622 999-1002 CC denotes and
T623 1003-1010 NN denotes absence
T624 1011-1018 NN denotes Protein
T625 1019-1025 NN denotes kinase
T626 1026-1027 NN denotes A
T627 1028-1038 NN denotes inhibition
T628 1039-1041 IN denotes by
T629 1042-1044 DT denotes an
T630 1045-1058 JJ denotes enzyme-linked
T631 1059-1072 JJ denotes immunosorbent
T632 1073-1078 NN denotes assay
T633 1079-1080 -LRB- denotes (
T634 1080-1085 NN denotes ELISA
T635 1085-1086 -RRB- denotes )
T636 1089-1096 NN denotes RESULTS
T637 1097-1100 NN denotes PTX
T638 1101-1104 VB denotes was
T639 1105-1117 VB denotes demonstrated
T640 1118-1120 TO denotes to
T641 1121-1134 RB denotes significantly
T642 1135-1141 VB denotes reduce
T643 1142-1153 JJ denotes cytoplasmic
T644 1154-1159 NN denotes I-κBα
T645 1160-1175 NN denotes phosphorylation
T646 1175-1176 -COMMA- denotes ,
T647 1177-1184 JJ denotes nuclear
T648 1185-1188 NN denotes p65
T649 1189-1204 NN denotes phosphorylation
T650 1204-1205 -COMMA- denotes ,
T651 1206-1209 CC denotes and
T652 1210-1213 DT denotes the
T653 1214-1217 NN denotes DNA
T654 1218-1225 NN denotes binding
T655 1226-1234 NN denotes activity
T656 1235-1237 IN denotes of
T657 1238-1243 NN denotes NF-κB
T658 1245-1247 IN denotes In
T659 1248-1256 NN denotes contrast
T660 1256-1257 -COMMA- denotes ,
T661 1258-1261 NN denotes PTX
T662 1262-1270 RB denotes markedly
T663 1271-1279 VB denotes enhanced
T664 1280-1283 DT denotes the
T665 1284-1299 NN denotes phosphorylation
T666 1300-1303 CC denotes and
T667 1304-1307 NN denotes DNA
T668 1308-1315 NN denotes binding
T669 1316-1324 NN denotes activity
T670 1325-1327 IN denotes of
T671 1328-1332 NN denotes CREB
T672 1334-1339 NN denotes Cells
T673 1340-1353 RB denotes concomitantly
T674 1354-1361 VB denotes treated
T675 1362-1366 IN denotes with
T676 1367-1370 NN denotes PTX
T677 1371-1374 CC denotes and
T678 1375-1378 NN denotes LPS
T679 1379-1387 VB denotes secreted
T680 1388-1395 JJ denotes similar
T681 1396-1402 NN denotes levels
T682 1403-1405 IN denotes of
T683 1406-1411 NN denotes TNF-α
T684 1412-1414 IN denotes in
T685 1415-1418 DT denotes the
T686 1419-1427 NN denotes presence
T687 1428-1431 CC denotes and
T688 1432-1439 NN denotes absence
T689 1440-1447 NN denotes Protein
T690 1448-1454 NN denotes kinase
T691 1455-1456 NN denotes A
T692 1457-1467 NN denotes inhibition
T693 1470-1480 NN denotes DISCUSSION
T694 1481-1484 DT denotes The
T695 1485-1494 VB denotes increased
T696 1495-1500 NN denotes level
T697 1501-1503 IN denotes of
T698 1504-1508 NN denotes cAMP
T699 1509-1513 WDT denotes that
T700 1514-1521 VB denotes results
T701 1522-1526 IN denotes from
T702 1527-1544 NN denotes phosphodiesterase
T703 1545-1555 NN denotes inhibition
T704 1556-1563 VB denotes affects
T705 1564-1575 JJ denotes cytoplasmic
T706 1576-1579 CC denotes and
T707 1580-1587 JJ denotes nuclear
T708 1588-1594 NN denotes events
T709 1594-1595 -COMMA- denotes ,
T710 1596-1605 VB denotes resulting
T711 1606-1608 IN denotes in
T712 1609-1612 DT denotes the
T713 1613-1624 NN denotes attenuation
T714 1625-1627 IN denotes of
T715 1628-1633 NN denotes NF-κB
T716 1634-1637 CC denotes and
T717 1638-1641 DT denotes the
T718 1642-1652 NN denotes activation
T719 1653-1655 IN denotes of
T720 1656-1660 NN denotes CREB
T721 1661-1676 JJ denotes transcriptional
T722 1677-1680 NN denotes DNA
T723 1681-1688 NN denotes binding
T724 1689-1696 IN denotes through
T725 1697-1705 NN denotes pathways
T726 1706-1710 WDT denotes that
T727 1711-1714 VB denotes are
T728 1715-1724 RB denotes partially
T729 1725-1732 NN denotes Protein
T730 1733-1739 NN denotes kinase
T731 1740-1753 JJ denotes A-independent
T732 1756-1766 NN denotes CONCLUSION
T733 1767-1779 JJ denotes PTX-mediated
T734 1780-1797 NN denotes phosphodiesterase
T735 1798-1808 NN denotes inhibition
T736 1809-1815 VB denotes occurs
T737 1816-1825 RB denotes partially
T738 1826-1833 IN denotes through
T739 1834-1835 DT denotes a
T740 1836-1843 NN denotes Protein
T741 1844-1850 NN denotes kinase
T742 1851-1864 JJ denotes A-independent
T743 1865-1872 NN denotes pathway
T744 1873-1876 CC denotes and
T745 1877-1880 MD denotes may
T746 1881-1886 VB denotes serve
T747 1887-1889 IN denotes as
T748 1890-1891 DT denotes a
T749 1892-1898 JJ denotes useful
T750 1899-1903 NN denotes tool
T751 1904-1906 IN denotes in
T752 1907-1910 DT denotes the
T753 1911-1922 NN denotes attenuation
T754 1923-1925 IN denotes of
T755 1926-1937 JJ denotes LPS-induced
T756 1938-1950 NN denotes inflammation
R2218 T2792 T2791 arg1Of study,this
R2219 T2792 T2793 arg1Of study,was
R365 T471 T470 arg1Of objective,The
R366 T471 T472 arg1Of objective,of
R367 T471 T475 arg1Of objective,was
R368 T474 T472 arg2Of study,of
R369 T474 T473 arg1Of study,this
R370 T477 T475 arg2Of determine,was
R371 T477 T476 arg1Of determine,to
R372 T479 T477 arg2Of effect,determine
R373 T479 T478 arg1Of effect,the
R374 T479 T480 arg1Of effect,of
R375 T479 T484 arg1Of effect,on
R376 T483 T480 arg2Of inhibition,of
R377 T483 T481 arg1Of inhibition,nonspecific
R378 T483 T482 arg1Of inhibition,phosphodiesterase
R379 T487 T485 arg1Of activation,transcription
R380 T487 T486 arg1Of activation,factor
R381 T487 T488 arg1Of activation,and
R382 T488 T484 arg2Of and,on
R383 T488 T496 arg1Of and,in
R384 T491 T489 arg1Of factor-alpha,tumor
R385 T491 T490 arg1Of factor-alpha,necrosis
R386 T491 T492 arg1Of factor-alpha,(
R387 T493 T492 arg2Of TNF-α,(
R388 T494 T492 arg3Of ),(
R389 T495 T488 arg2Of production,and
R390 T495 T491 arg1Of production,factor-alpha
R391 T499 T498 arg2Of LPS,(
R392 T500 T498 arg3Of ),(
R393 T501 T497 arg1Of -stimulated,lipopolysaccharide
R394 T501 T498 arg1Of -stimulated,(
R395 T504 T496 arg2Of cells,in
R396 T504 T501 arg1Of cells,-stimulated
R397 T504 T502 arg1Of cells,human
R398 T504 T503 arg1Of cells,mononuclear
R399 T507 T506 arg1Of production,The
R400 T507 T508 arg1Of production,of
R401 T507 T510 arg1Of production,following
R402 T507 T513 arg1Of production,is
R403 T509 T508 arg2Of TNF-α,of
R404 T512 T510 arg2Of stimulation,following
R405 T512 T511 arg1Of stimulation,LPS
R406 T514 T513 arg2Of one,is
R407 T514 T515 arg1Of one,of
R408 T518 T515 arg2Of steps,of
R409 T518 T516 arg1Of steps,the
R410 T518 T517 arg1Of steps,key
R411 T518 T519 arg1Of steps,in
R412 T521 T522 arg1Of sepsis,and
R413 T522 T519 arg2Of and,in
R414 T522 T520 arg1Of and,bacterial
R415 T523 T522 arg2Of inflammation,and
R416 T525 T524 arg1Of mechanism,The
R417 T525 T526 arg2Of mechanism,by
R418 T525 T527 arg1Of mechanism,which
R419 T525 T538 arg1Of mechanism,remains
R420 T525 T539 arg1Of mechanism,unclear
R421 T529 T528 arg1Of inhibition,phosphodiesterase
R422 T529 T530 arg1Of inhibition,alters
R423 T530 T526 arg1Of alters,by
R424 T530 T533 arg1Of alters,in
R425 T532 T530 arg2Of production,alters
R426 T532 T531 arg1Of production,TNF-α
R427 T535 T533 arg2Of presence,in
R428 T535 T534 arg1Of presence,the
R429 T535 T536 arg1Of presence,of
R430 T537 T536 arg2Of LPS,of
R431 T539 T538 arg2Of unclear,remains
R432 T543 T541 arg1Of cells,Human
R433 T543 T542 arg1Of cells,mononuclear
R434 T543 T544 arg1Of cells,were
R435 T543 T545 arg2Of cells,stimulated
R436 T545 T544 arg2Of stimulated,were
R437 T545 T546 arg1Of stimulated,with
R438 T547 T546 arg2Of LPS,with
R439 T547 T548 arg1Of LPS,(
R440 T547 T552 arg1Of LPS,","
R441 T547 T553 arg1Of LPS,in
R442 T547 T566 arg1Of LPS,","
R443 T550 T548 arg2Of μg/mL,(
R444 T550 T549 arg1Of μg/mL,1
R445 T551 T548 arg3Of ),(
R446 T555 T556 arg1Of presence,and
R447 T556 T553 arg2Of and,in
R448 T556 T554 arg1Of and,the
R449 T556 T558 arg1Of and,of
R450 T557 T556 arg2Of absence,and
R451 T559 T558 arg2Of Pentoxifylline,of
R452 T559 T560 arg1Of Pentoxifylline,(
R453 T561 T562 arg1Of PTX,;
R454 T562 T560 arg2Of ;,(
R455 T564 T562 arg2Of mM,;
R456 T564 T563 arg1Of mM,20
R457 T565 T560 arg3Of ),(
R458 T570 T566 arg2Of inhibitor,","
R459 T570 T567 arg1Of inhibitor,a
R460 T570 T568 arg1Of inhibitor,nonspecific
R461 T570 T569 arg1Of inhibitor,phosphodiesterase
R462 T572 T571 arg1Of blotting,Western
R463 T572 T573 arg1Of blotting,of
R464 T572 T594 arg1Of blotting,was
R465 T572 T595 arg2Of blotting,performed
R466 T576 T574 arg2Of I-κBα,phosphorylated
R467 T576 T575 arg1Of I-κBα,cytoplasmic
R468 T576 T577 arg1Of I-κBα,","
R469 T577 T585 arg1Of ",",and
R470 T580 T577 arg2Of p65,","
R471 T580 T578 arg1Of p65,nuclear
R472 T580 T579 arg1Of p65,factor-κB
R473 T580 T581 arg1Of p65,(
R474 T582 T581 arg2Of NF-κB,(
R475 T583 T581 arg3Of ),(
R476 T585 T573 arg2Of and,of
R477 T585 T584 arg1Of and,","
R478 T590 T585 arg2Of protein,and
R479 T590 T586 arg1Of protein,nuclear
R480 T590 T587 arg1Of protein,cAMP-response
R481 T590 T588 arg1Of protein,element
R482 T590 T589 arg1Of protein,binding
R483 T590 T591 arg1Of protein,(
R484 T592 T591 arg2Of CREB,(
R485 T593 T591 arg3Of ),(
R486 T595 T594 arg2Of performed,was
R487 T597 T596 arg1Of binding,DNA
R488 T597 T598 arg1Of binding,of
R489 T597 T602 arg1Of binding,was
R490 T597 T603 arg2Of binding,verified
R491 T599 T600 arg1Of NF-κB,and
R492 T600 T598 arg2Of and,of
R493 T601 T600 arg2Of CREB,and
R494 T603 T602 arg2Of verified,was
R495 T608 T603 arg1Of assay,verified
R496 T608 T604 arg2Of assay,by
R497 T608 T605 arg1Of assay,electrophoretic
R498 T608 T606 arg1Of assay,mobility
R499 T608 T607 arg1Of assay,shift
R500 T610 T609 arg1Of levels,TNF-α
R501 T610 T611 arg1Of levels,were
R502 T610 T612 arg2Of levels,determined
R503 T612 T611 arg2Of determined,were
R504 T612 T613 arg1Of determined,in
R505 T612 T619 arg1Of determined,in
R506 T615 T613 arg2Of supernatant,in
R507 T615 T614 arg1Of supernatant,the
R508 T615 T616 arg1Of supernatant,of
R509 T618 T616 arg2Of cells,of
R510 T618 T617 arg2Of cells,stimulated
R511 T621 T622 arg1Of presence,and
R512 T623 T622 arg2Of absence,and
R513 T627 T619 arg2Of inhibition,in
R514 T627 T620 arg1Of inhibition,the
R515 T627 T621 arg1Of inhibition,presence
R516 T627 T623 arg1Of inhibition,absence
R517 T627 T624 arg1Of inhibition,Protein
R518 T627 T625 arg1Of inhibition,kinase
R519 T627 T626 arg1Of inhibition,A
R520 T627 T628 arg1Of inhibition,by
R521 T632 T628 arg2Of assay,by
R522 T632 T629 arg1Of assay,an
R523 T632 T630 arg1Of assay,enzyme-linked
R524 T632 T631 arg1Of assay,immunosorbent
R525 T632 T633 arg1Of assay,(
R526 T634 T633 arg2Of ELISA,(
R527 T635 T633 arg3Of ),(
R528 T637 T638 arg1Of PTX,was
R529 T637 T639 arg2Of PTX,demonstrated
R530 T637 T642 arg1Of PTX,reduce
R531 T639 T638 arg2Of demonstrated,was
R532 T642 T639 arg3Of reduce,demonstrated
R533 T642 T640 arg1Of reduce,to
R534 T642 T641 arg1Of reduce,significantly
R535 T645 T643 arg1Of phosphorylation,cytoplasmic
R536 T645 T644 arg1Of phosphorylation,I-κBα
R537 T645 T646 arg1Of phosphorylation,","
R538 T646 T651 arg1Of ",",and
R539 T649 T646 arg2Of phosphorylation,","
R540 T649 T647 arg1Of phosphorylation,nuclear
R541 T649 T648 arg1Of phosphorylation,p65
R542 T651 T642 arg2Of and,reduce
R543 T651 T650 arg1Of and,","
R544 T655 T651 arg2Of activity,and
R545 T655 T652 arg1Of activity,the
R546 T655 T653 arg1Of activity,DNA
R547 T655 T654 arg1Of activity,binding
R548 T655 T656 arg1Of activity,of
R549 T657 T656 arg2Of NF-κB,of
R550 T659 T658 arg2Of contrast,In
R551 T661 T663 arg1Of PTX,enhanced
R552 T663 T658 arg1Of enhanced,In
R553 T663 T660 arg1Of enhanced,","
R554 T663 T662 arg1Of enhanced,markedly
R555 T665 T666 arg1Of phosphorylation,and
R556 T666 T663 arg2Of and,enhanced
R557 T666 T664 arg1Of and,the
R558 T666 T670 arg1Of and,of
R559 T669 T666 arg2Of activity,and
R560 T669 T667 arg1Of activity,DNA
R561 T669 T668 arg1Of activity,binding
R562 T671 T670 arg2Of CREB,of
R563 T672 T674 arg2Of Cells,treated
R564 T672 T679 arg1Of Cells,secreted
R565 T674 T673 arg1Of treated,concomitantly
R566 T674 T675 arg1Of treated,with
R567 T676 T677 arg1Of PTX,and
R568 T677 T675 arg2Of and,with
R569 T678 T677 arg2Of LPS,and
R570 T681 T679 arg2Of levels,secreted
R571 T681 T680 arg1Of levels,similar
R572 T681 T682 arg1Of levels,of
R573 T681 T684 arg1Of levels,in
R574 T683 T682 arg2Of TNF-α,of
R575 T686 T687 arg1Of presence,and
R576 T688 T687 arg2Of absence,and
R577 T692 T684 arg2Of inhibition,in
R578 T692 T685 arg1Of inhibition,the
R579 T692 T686 arg1Of inhibition,presence
R580 T692 T688 arg1Of inhibition,absence
R581 T692 T689 arg1Of inhibition,Protein
R582 T692 T690 arg1Of inhibition,kinase
R583 T692 T691 arg1Of inhibition,A
R584 T696 T694 arg1Of level,The
R585 T696 T695 arg2Of level,increased
R586 T696 T697 arg1Of level,of
R587 T696 T699 arg1Of level,that
R588 T696 T700 arg1Of level,results
R589 T696 T704 arg1Of level,affects
R590 T698 T697 arg2Of cAMP,of
R591 T700 T701 arg1Of results,from
R592 T703 T701 arg2Of inhibition,from
R593 T703 T702 arg1Of inhibition,phosphodiesterase
R594 T704 T709 arg1Of affects,","
R595 T704 T710 modOf affects,resulting
R596 T705 T706 arg1Of cytoplasmic,and
R597 T707 T706 arg2Of nuclear,and
R598 T708 T704 arg2Of events,affects
R599 T708 T705 arg1Of events,cytoplasmic
R600 T708 T707 arg1Of events,nuclear
R601 T710 T711 arg1Of resulting,in
R602 T710 T724 arg1Of resulting,through
R603 T713 T712 arg1Of attenuation,the
R604 T713 T714 arg1Of attenuation,of
R605 T713 T716 arg1Of attenuation,and
R606 T715 T714 arg2Of NF-κB,of
R607 T716 T711 arg2Of and,in
R608 T718 T716 arg2Of activation,and
R609 T718 T717 arg1Of activation,the
R610 T718 T719 arg1Of activation,of
R611 T723 T719 arg2Of binding,of
R612 T723 T720 arg1Of binding,CREB
R613 T723 T721 arg1Of binding,transcriptional
R614 T723 T722 arg1Of binding,DNA
R615 T725 T724 arg2Of pathways,through
R616 T725 T726 arg1Of pathways,that
R617 T725 T727 arg1Of pathways,are
R618 T725 T731 arg1Of pathways,A-independent
R619 T727 T728 arg1Of are,partially
R620 T731 T727 arg2Of A-independent,are
R621 T731 T729 arg1Of A-independent,Protein
R622 T731 T730 arg1Of A-independent,kinase
R623 T735 T733 arg1Of inhibition,PTX-mediated
R624 T735 T734 arg1Of inhibition,phosphodiesterase
R625 T735 T736 arg1Of inhibition,occurs
R626 T735 T745 arg1Of inhibition,may
R627 T735 T746 arg1Of inhibition,serve
R628 T736 T737 arg1Of occurs,partially
R629 T736 T738 arg1Of occurs,through
R630 T736 T744 arg1Of occurs,and
R631 T743 T738 arg2Of pathway,through
R632 T743 T739 arg1Of pathway,a
R633 T743 T740 arg1Of pathway,Protein
R634 T743 T741 arg1Of pathway,kinase
R635 T743 T742 arg1Of pathway,A-independent
R636 T746 T744 arg2Of serve,and
R637 T746 T745 arg2Of serve,may
R638 T746 T747 arg1Of serve,as
R639 T750 T747 arg2Of tool,as
R640 T750 T748 arg1Of tool,a
R641 T750 T749 arg1Of tool,useful
R642 T750 T751 arg1Of tool,in
R643 T753 T751 arg2Of attenuation,in
R644 T753 T752 arg1Of attenuation,the
R645 T753 T754 arg1Of attenuation,of
R646 T756 T754 arg2Of inflammation,of
R647 T756 T755 arg1Of inflammation,LPS-induced